HomeresearchBeta blockers are potent cancer drugs - stress causes cancer

Beta blockers are potent cancer drugs – stress causes cancer

-

Stress triggers cancer, stress increases cancer growth – pharmaceutical stress inhibition with beta blockers has a powerful effect against cancer!

  • this posting was created 2017, since then many more studies have confirmed what is presented her

Stress promotes cancer

at least since the exciting observations of the radiologist / radiotherapist / oncologist Dr. Carl Simonton we have known about the power of the psyche in the development of cancer. Dr. Simonton is considered the developer of “psycho-oncology“.

How does the psyche or stress really affect cancer?

Our everyday experience tells us that the psyche influences illnesses. But how does this actually happen “mechanically”?

Biochemistry of “contentment”

Stress leads to the release of adrenaline / noradrenaline and cortisol, also influences serotonin and endorphins, probably also oxytocin.

These hormones influence mood, the psyche, the basic emotional state.

Hormones influence the psyche AND cancer

Long-term stress leads to immune deficiency due to the constant cortisol stimulation – like cortisone therapy.

Adrenaline/noradrenaline have a stressful effect on so-called BETA receptors: high heart rate, internal trembling, cold hands, sweating, “internally rushed”.

Stress also lowers the serotonin level (happiness hormone, libido, temperature, appetite) and the endorphin level (reward hormone, pain relief, contentment).

Endorphins affect cancer

This important interface between body and soul and its effect on cancer was first researched and used in the 1980s: Endorphins as powerful immune modulators:

Cancer cells have endorphin receptors on their surface; stimulating these receptors with endorphins (reward hormones) slows growth, while endorphin deficiency accelerates growth.

We have been using LDN (artificial endorphins) in practice since 2010 and see that patients actually achieve an improvement in their prognosis.

But another part of the body’s biochemical stress management was only recently discovered to be crucial for oncology

 

Adrenaline and beta receptors stimulate cancer growth

What was new to me, however, was that the normal vegetative stress system can also influence the development of cancer.

Latest study from 2016: Beta blockers inhibit cancer growth

I almost fell over when I found > >2000 studies on the subject of beta blockers and cancer.

FRYDA with her adrenaline theory

In her unsystematic book, Dr. Fryda says that adrenaline deficiency leads to cancer: this actually seems completely obsolete due to the large number of studies citing the opposite – ADRENALIN promotes Cancer and cancer-growth! 

 

Which types of cancer have already been researched

Carcinomas

Pancreas (2016): stress promotes growth, catecholamines such as adrenaline and noradrenaline promote tumor growth, beta-blockers (propranolol) counteract this and significantly inhibit tumor growth (70%) via inhibition of TREGs and immunosuppressive cytokines and hormones.

Ovarian cancer 2016: 3 x longer survival time with beta-blockers – further comments on this study speak of “miracle treatment”

Colon cancer (2015): Propranolol, carvedilol, IPI – effective via the ß-adrenoreceptors, liver metastases of colon cancer significantly reduced in mice with ß-blockers (2015 FullText)

Tripple negative breast cancer (2016): Propranolol administered perioperatively inhibits the ß2 receptors and significantly reduces postoperative brain metastases

Breast cancer 2016: retrospective study on the outcome of breast cancer patients depending on their blood pressure medication: those with beta-blockers had significantly better chances of survival, fewer relapses, lower death rate … | this could not be achieved with ACE or AT1 blood pressure medications

Breast cancer 2015: Metastasis phenotype of cancer cells significantly inhibited by ß-blockers!

Breast cancer 2015 – meta-analysis: clear advantage for patients with ß-blockers: relapse and progression-free interval, OL etc. everything better with ß-blockers

 

Sarcomas

Angiosarcomas are treatable for the first time (2015): Combination of chemo + 3 x 40mg propranolol has now brought a patient into regression for 2 years, normally 0% OL

Angiomas in tuberous sclerosis with topical ß-blockers (2015): growth was significantly inhibited in a “split-face” experiment (only half of the face was treated).

Kaposi’s sarcoma (virus-induced, 2015): growth was significantly inhibited

 

Hemangiomas in children

Hemangiomas in newborns (2015): half of the hemangiomas disappeared with beta-blockers, numerous studies ( > 670) on the topic of newborn hemangiomas and beta-blockers. Here, cardioselective ß1 blockers (atenolol) and non-selective ones (propranolol) are equally helpful: 53 vs. 60% study 2014

Hematological diseases

Leukemia 2009 in vitro significant sensitivity of various leukemia cells to beta blockers

Leukemia 2009 Hematopoietic leukemic stem cells significantly. inhibited by beta-blockers (FullText)

chronic stress promotes the progression of leukemia via beta receptors (2012)

 

 

Conclusion

I don’t need to research any further, we now have a wonderful additional tool in our hands to slow down cancer universally!

 

 

 

Google CENSORSHIP!

Google censors my homepage quite a bit, sometimes I am not even able to find my articles on Google. So please sign up for the newsletter and share it with friends or via Facebook and use the search function on my website. Follow me on Twitter, where I also announce important articles.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

×